Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of BioVie Inc (NASDAQ: BIVI) was $0.47 for the day, down -3.40% from the previous closing price of $0.49. In other words, the price has decreased by -$3.40 from its previous closing price. On the day, 0.61 million shares were traded. BIVI stock price reached its highest trading level at $0.4975 during the session, while it also had its lowest trading level at $0.4551.
Ratios:
Our analysis of BIVI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.47 and its Current Ratio is at 1.47. In the meantime, Its Debt-to-Equity ratio is 1.37 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 22, 2022, initiated with a Overweight rating and assigned the stock a target price of $7.
On January 15, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $47.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 01 ’23 when GORLIN STEVE sold 75,680 shares for $1.69 per share. The transaction valued at 127,899 led to the insider holds 46,358 shares of the business.
DO CUONG V bought 10,000 shares of BIVI for $17,800 on Nov 30 ’23. The President & CEO now owns 68,759 shares after completing the transaction at $1.78 per share. On Sep 05 ’23, another insider, GORLIN STEVE, who serves as the Director of the company, sold 8,560 shares for $3.05 each. As a result, the insider received 26,108 and left with 75,680 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BIVI now has a Market Capitalization of 25891456 and an Enterprise Value of 9480392.
Stock Price History:
The Beta on a monthly basis for BIVI is 1.22, which has changed by -0.94045514 over the last 52 weeks, in comparison to a change of 0.2160933 over the same period for the S&P500. Over the past 52 weeks, BIVI has reached a high of $8.69, while it has fallen to a 52-week low of $0.44. The 50-Day Moving Average of the stock is -43.50%, while the 200-Day Moving Average is calculated to be -81.45%.
Shares Statistics:
BIVI traded an average of 2.55M shares per day over the past three months and 859480 shares per day over the past ten days. A total of 36.43M shares are outstanding, with a floating share count of 33.20M. Insiders hold about 39.55% of the company’s shares, while institutions hold 3.90% stake in the company. Shares short for BIVI as of 1711584000 were 1478650 with a Short Ratio of 0.58, compared to 1709164800 on 1019076. Therefore, it implies a Short% of Shares Outstanding of 1478650 and a Short% of Float of 4.71.
Earnings Estimates
The market rating of BioVie Inc (BIVI) is currently shaped by the ongoing analysis conducted by 1 analysts closely monitoring its performance.On average, analysts expect EPS of -$0.33 for the current quarter, with a high estimate of -$0.33 and a low estimate of -$0.33, while EPS last year was -$0.43. The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.34 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$1.28 and -$1.28 for the fiscal current year, implying an average EPS of -$1.28. EPS for the following year is -$1.3, with 1 analysts recommending between -$1.3 and -$1.3.
